|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 7/29/16 Amgen Inc 10-Q 6/30/16 72:10M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 763K
2: EX-31 Rule 13A-14(A) Certifications HTML 36K
3: EX-32 Section 1350 Certifications HTML 25K
10: R1 Document and Entity Information HTML 39K
11: R2 Condensed Consolidated Statements of Income HTML 77K
(Unaudited)
12: R3 Condensed Consolidated Statements of Comprehensive HTML 45K
Income (Unaudited)
13: R4 Condensed Consolidated Balance Sheets (Unaudited) HTML 91K
14: R5 Condensed Consolidated Balance Sheets (Unaudited) HTML 27K
(Parenthetical)
15: R6 Condensed Consolidated Statements of Cash Flows HTML 106K
(Unaudited)
16: R7 Summary of significant accounting policies HTML 38K
17: R8 Restructuring HTML 27K
18: R9 Business combinations HTML 33K
19: R10 Income taxes HTML 32K
20: R11 Earnings per share HTML 55K
21: R12 Available-for-sale investments HTML 219K
22: R13 Inventories HTML 30K
23: R14 Goodwill and other intangible assets HTML 85K
24: R15 Financing arrangements HTML 105K
25: R16 Stockholders' equity HTML 144K
26: R17 Fair value measurement HTML 220K
27: R18 Derivative instruments HTML 183K
28: R19 Contingencies and commitments HTML 40K
29: R20 Summary of significant accounting policies HTML 50K
(Policies)
30: R21 Business combinations (Tables) HTML 25K
31: R22 Earnings per share (Tables) HTML 52K
32: R23 Available-for-sale investments (Tables) HTML 220K
33: R24 Inventories (Tables) HTML 31K
34: R25 Goodwill and other intangible assets (Tables) HTML 76K
35: R26 Financing arrangements (Tables) HTML 97K
36: R27 Stockholders' equity (Tables) HTML 140K
37: R28 Fair value measurement (Tables) HTML 201K
38: R29 Derivative instruments (Tables) HTML 167K
39: R30 Summary of significant accounting policies HTML 42K
(Details)
40: R31 Restructuring (Details) HTML 40K
41: R32 Business combinations (Aggregate Consideration HTML 28K
Paid - Dezima) (Details)
42: R33 Business combinations (Details Textual) HTML 37K
43: R34 Income taxes (Details) HTML 31K
44: R35 Earnings per share (Details) HTML 42K
45: R36 Available-for-sale investments (Details) HTML 71K
46: R37 Available-for-sale investments (Fair Values by HTML 36K
Classification) (Details)
47: R38 Available-for-sale investments (Fair Values by HTML 42K
Contractual Maturity) (Details)
48: R39 Available-for-sale investments (Unrealized Losses HTML 63K
and Fair Values) (Details)
49: R40 Available-for-sale investments (Details Textual) HTML 30K
50: R41 Inventories (Details) HTML 31K
51: R42 Goodwill and other intangible assets (Goodwill HTML 29K
Roll Forward) (Details)
52: R43 Goodwill and other intangible assets (Idenfitiable HTML 52K
Intangible Assets) (Details)
53: R44 Goodwill and other intangible assets (Details HTML 41K
Textual)
54: R45 Financing arrangements (Principal Amounts and HTML 168K
Carrying Value of Long-term Borrowings) (Details)
55: R46 Financing arrangements (Details Textual) HTML 112K
56: R47 Financing arrangements (Debt Exchange) (Details) HTML 37K
57: R48 Stockholders' equity (Share Repurchase Program) HTML 28K
(Details)
58: R49 Stockholders' equity (Details Textual) HTML 31K
59: R50 Stockholders' equity (Components of AOCI) HTML 58K
(Details)
60: R51 Stockholders' equity (Reclassifications out of HTML 54K
AOCI) (Details)
61: R52 Fair value measurement (Details) HTML 181K
62: R53 Fair value measurement (Changes in Contingent HTML 31K
Consideration Obligation) (Details)
63: R54 Fair value measurements (Details Textual) HTML 42K
64: R55 Derivative instruments (Details Textual) HTML 65K
65: R56 Derivative instruments (Cross-currency Swaps) HTML 57K
(Details)
66: R57 Derivative instruments (Effective Portion of HTML 33K
Unrealized Gain (Loss)) (Details)
67: R58 Derivative instruments (Locations and Effective HTML 49K
Portions of Gain (Loss) Reclassified out of AOCI)
(Details)
68: R59 Derivative instruments (Locations and Gain (Loss) HTML 27K
for Derivatives Not Designated as Hedging
Instruments) (Details)
69: R60 Derivative instruments (Fair Value of Derivatives) HTML 55K
(Details)
71: XML IDEA XML File -- Filing Summary XML 134K
70: EXCEL IDEA Workbook of Financial Reports XLSX 86K
4: EX-101.INS XBRL Instance -- amgn-20160630 XML 3.76M
6: EX-101.CAL XBRL Calculations -- amgn-20160630_cal XML 189K
7: EX-101.DEF XBRL Definitions -- amgn-20160630_def XML 644K
8: EX-101.LAB XBRL Labels -- amgn-20160630_lab XML 1.45M
9: EX-101.PRE XBRL Presentations -- amgn-20160630_pre XML 907K
5: EX-101.SCH XBRL Schema -- amgn-20160630 XSD 166K
72: ZIP XBRL Zipped Folder -- 0000318154-16-000046-xbrl Zip 244K
| Exhibit |
(i) | the accompanying Quarterly Report on Form 10-Q of the Company for the period ended June 30, 2016 (the “Report”) fully complies with the requirements
of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and |
(ii) | information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated: July 29, 2016 | |
Chairman of the Board, | |
Chief Executive Officer and President | |
(i) | the accompanying Quarterly Report on Form 10-Q of the
Company for the period ended June 30, 2016 (the “Report”) fully complies with the requirements of Section 13(a) or Section 15(d), as applicable, of the Securities Exchange Act of 1934, as amended; and |
(ii) | information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. |
Dated:
July 29, 2016 | /s/ DAVID W. MELINE |
Executive Vice President and Chief Financial Officer | |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 7/29/16 | None on these Dates | ||
| For Period end: | 6/30/16 | |||
| List all Filings | ||||